Can ACTH therapy improve the long-term outcome of drug-resistant frontal lobe epilepsy?

Giuseppe Gobbi, Giulia Loiacono, Antonella Boni, Lucia Marangio, Alberto Verrotti

Research output: Contribution to journalArticle

Abstract

Frontal lobe epilepsy is a common focal epilepsy in children and is often difficult to treat. Adrenocorticotropic hormone (ACTH) or steroids have been used for patients with several forms of medically intractable epilepsy. We evaluated the short, medium, and long-term evolution of patients with frontal lobe epilepsy and secondary bilateral synchrony on the EEG, who received ACTH treatment. Patients were recruited for an add-on trial during clinical practice, and data was retrospectively analysed. The study group comprised 6 patients treated with ACTH. The effects of ACTH were assessed in the short term (at the end of a 6-week period of ACTH treatment), medium term (at 6 months after the end of treatment), and long term (at 12 months after the end of treatment). At short-term follow-up, ACTH treatment was effective for all types of seizures in 5 of 6 patients and ineffective in 1 patient. All patients who were seizure-free at the end of ACTH treatment maintained an excellent outcome, remaining seizure-free at the end of follow-up. Our study demonstrates that ACTH may represent an effective treatment for frontal lobe epilepsy with secondary bilateral synchrony. Further double-blind prospective studies are required to confirm our initial findings.

Original languageEnglish
Pages (from-to)185-190
Number of pages6
JournalEpileptic Disorders
Volume16
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Frontal Lobe Epilepsy
Adrenocorticotropic Hormone
Seizures
Therapeutics
Partial Epilepsy
Drug Resistant Epilepsy
Double-Blind Method
Electroencephalography
Steroids
Clinical Trials
Prospective Studies

Keywords

  • ACTH
  • Antiepileptic drug
  • Epilepsy
  • Frontal lobe epilepsy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Can ACTH therapy improve the long-term outcome of drug-resistant frontal lobe epilepsy? / Gobbi, Giuseppe; Loiacono, Giulia; Boni, Antonella; Marangio, Lucia; Verrotti, Alberto.

In: Epileptic Disorders, Vol. 16, No. 2, 2014, p. 185-190.

Research output: Contribution to journalArticle

Gobbi, Giuseppe ; Loiacono, Giulia ; Boni, Antonella ; Marangio, Lucia ; Verrotti, Alberto. / Can ACTH therapy improve the long-term outcome of drug-resistant frontal lobe epilepsy?. In: Epileptic Disorders. 2014 ; Vol. 16, No. 2. pp. 185-190.
@article{fa96da0544a944f0a209d492c3f4d37a,
title = "Can ACTH therapy improve the long-term outcome of drug-resistant frontal lobe epilepsy?",
abstract = "Frontal lobe epilepsy is a common focal epilepsy in children and is often difficult to treat. Adrenocorticotropic hormone (ACTH) or steroids have been used for patients with several forms of medically intractable epilepsy. We evaluated the short, medium, and long-term evolution of patients with frontal lobe epilepsy and secondary bilateral synchrony on the EEG, who received ACTH treatment. Patients were recruited for an add-on trial during clinical practice, and data was retrospectively analysed. The study group comprised 6 patients treated with ACTH. The effects of ACTH were assessed in the short term (at the end of a 6-week period of ACTH treatment), medium term (at 6 months after the end of treatment), and long term (at 12 months after the end of treatment). At short-term follow-up, ACTH treatment was effective for all types of seizures in 5 of 6 patients and ineffective in 1 patient. All patients who were seizure-free at the end of ACTH treatment maintained an excellent outcome, remaining seizure-free at the end of follow-up. Our study demonstrates that ACTH may represent an effective treatment for frontal lobe epilepsy with secondary bilateral synchrony. Further double-blind prospective studies are required to confirm our initial findings.",
keywords = "ACTH, Antiepileptic drug, Epilepsy, Frontal lobe epilepsy",
author = "Giuseppe Gobbi and Giulia Loiacono and Antonella Boni and Lucia Marangio and Alberto Verrotti",
year = "2014",
doi = "10.1684/epd.2014.0656",
language = "English",
volume = "16",
pages = "185--190",
journal = "Epileptic Disorders",
issn = "1294-9361",
publisher = "Springer Paris",
number = "2",

}

TY - JOUR

T1 - Can ACTH therapy improve the long-term outcome of drug-resistant frontal lobe epilepsy?

AU - Gobbi, Giuseppe

AU - Loiacono, Giulia

AU - Boni, Antonella

AU - Marangio, Lucia

AU - Verrotti, Alberto

PY - 2014

Y1 - 2014

N2 - Frontal lobe epilepsy is a common focal epilepsy in children and is often difficult to treat. Adrenocorticotropic hormone (ACTH) or steroids have been used for patients with several forms of medically intractable epilepsy. We evaluated the short, medium, and long-term evolution of patients with frontal lobe epilepsy and secondary bilateral synchrony on the EEG, who received ACTH treatment. Patients were recruited for an add-on trial during clinical practice, and data was retrospectively analysed. The study group comprised 6 patients treated with ACTH. The effects of ACTH were assessed in the short term (at the end of a 6-week period of ACTH treatment), medium term (at 6 months after the end of treatment), and long term (at 12 months after the end of treatment). At short-term follow-up, ACTH treatment was effective for all types of seizures in 5 of 6 patients and ineffective in 1 patient. All patients who were seizure-free at the end of ACTH treatment maintained an excellent outcome, remaining seizure-free at the end of follow-up. Our study demonstrates that ACTH may represent an effective treatment for frontal lobe epilepsy with secondary bilateral synchrony. Further double-blind prospective studies are required to confirm our initial findings.

AB - Frontal lobe epilepsy is a common focal epilepsy in children and is often difficult to treat. Adrenocorticotropic hormone (ACTH) or steroids have been used for patients with several forms of medically intractable epilepsy. We evaluated the short, medium, and long-term evolution of patients with frontal lobe epilepsy and secondary bilateral synchrony on the EEG, who received ACTH treatment. Patients were recruited for an add-on trial during clinical practice, and data was retrospectively analysed. The study group comprised 6 patients treated with ACTH. The effects of ACTH were assessed in the short term (at the end of a 6-week period of ACTH treatment), medium term (at 6 months after the end of treatment), and long term (at 12 months after the end of treatment). At short-term follow-up, ACTH treatment was effective for all types of seizures in 5 of 6 patients and ineffective in 1 patient. All patients who were seizure-free at the end of ACTH treatment maintained an excellent outcome, remaining seizure-free at the end of follow-up. Our study demonstrates that ACTH may represent an effective treatment for frontal lobe epilepsy with secondary bilateral synchrony. Further double-blind prospective studies are required to confirm our initial findings.

KW - ACTH

KW - Antiepileptic drug

KW - Epilepsy

KW - Frontal lobe epilepsy

UR - http://www.scopus.com/inward/record.url?scp=84904390961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904390961&partnerID=8YFLogxK

U2 - 10.1684/epd.2014.0656

DO - 10.1684/epd.2014.0656

M3 - Article

C2 - 24776014

AN - SCOPUS:84904390961

VL - 16

SP - 185

EP - 190

JO - Epileptic Disorders

JF - Epileptic Disorders

SN - 1294-9361

IS - 2

ER -